Disclosures
Massimo Pandolfo, MD, FAAN
| Scientific Advisory Boards | |
| (1) Voyager Therapeutics, Scientific Advisory Board (2) Biomarin, Scientific Advisory Board (3) Minoryx, Scientific Advisory Board | |
| Editorial Boards | |
| (1) Acta Neurologica Belgica, Editorial Board Member, 2011- (2) Orphanet Journal of Rare Diseases, Editorial Board Member, 2013- (3) Neurology Genetics, Associate Editor, 2015-, Deputy Editor, 2018- | |
| Patents | |
| (1) Direct molecular diagnosis of Friedreich's ataxia. M. Pandolfo, L. Montermini, M.D.L. Molto, M. Koenig, V. Campuzano, M. Cossée. US patent (2000) 6, 150, 091, WO patent (1997) 9705234. | |
| Consultancies | |
| (1) Chiesi Canada | |
| Research Support, Commercial Entities | |
| (1) Biomarin (2) Voyager Therapeutics | |
| Research Support, Government Entities | |
| (1) Fonds National de la Recherche Scientifique (Belgium) | |
| Research Support, Foundations and Societies | |
| (1) Offrez-moi-la-lune (2) Friedreich's Ataxia Research Alliance (3) Euroataxia | |
| Stock/Stock Options/Board of Directors Compensation | |
| (1) Voyager Therapeutics | |
| Royalty Payments, Technology or Inventions | |
| (1) Friedreich's ataxia diagnostic test, Athena Diagnostics, since 1997 | |